Please login to the form below

Not currently logged in
Email:
Password:

Emend

This page shows the latest Emend news and features for those working in and with pharma, biotech and healthcare.

CHMP October meeting gives recommendations for Pfizer and MSD

CHMP October meeting gives recommendations for Pfizer and MSD

Merck Sharpe &Dohme's Emend (aprepitant) was further recommended for the prevention of nausea and vomiting in child chemotherapy patients from the age of 6 months to 12 years.

Latest news

  • Merck plans expanded filing for Emend this year Merck plans expanded filing for Emend this year

    Merck &Co's nausea and vomiting therapy Emend is effective in preventing chemotherapy-induced nausea and vomiting (CINV) even when given as a single dose, says a new study. ... Emend has been a solid product for Merck &Co, with sales last year rising 9%

  • Breathing easier

    Allergic rhinitis . Japan. Aprepitant . Emend (Ono Pharmaceutical). Chemotherapy-induced nausea and vomiting  .

  • Breathing life Breathing life

    Aprepitant. Emend (Ono Pharmaceutical). Chemotherapy induced nausea and vomiting. Japan. Sitagliptin.

  • Cost of living

    For example, anti-nausea drugs in the NK-1 class such as Emend make chemotherapy more manageable for high-need patients, thereby improving the likelihood of success for the primary therapy.

  • Elan and J&JPRD submit NDA for novel Invega reformulation

    Rapamune (sirolimus), which is marketed by Wyeth: and the anti-emetic treatment Emend (aprepitant), which is marketed by Merck &Co.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics